top of page
CanCan Diagnostic
CanCan Diagnostic is a pioneer in liquid biopsy for dogs offering a painless, affordable and accurate way to detect most cancer types.
Parsing Holding, together with a partner, took a majority position in the business to help founder and CEO Maciej Parys and his team developping further the business worldwide.
Project type
Majority Investment
Date
September 2025
Location
Edinburgh, Scotland

01
CanCan Diagnostic
No media to show yet
Add media to this gallery, or connect to data.
bottom of page